SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
496Opportunist PR of the day... Nastech Pharmaceutical Company Inc. to Host Webinanigel bates-10/31/2006
495Should not be a problem.kenhott-10/31/2006
494Any question of antitrust issues given Merck's investment in Alnylam ? Aftenigel bates-10/31/2006
493Unbelievable! Congrads to all the holders.kenhott-10/31/2006
492Ka-ching. Too bad I have such a paltry position. Better than a poke in the eyeThomas-10/31/2006
491Merck buying RNAI for $1.1bn.nigel bates-10/30/2006
490How Gene Silencing May Provide Cures Recent Nobel laureate Andrew Fire talks abdr.praveen-10/27/2006
489>>454 Sequencing(TM) Reveals New Pathway in RNA Interference Wednesday Octuck-10/25/2006
488Bravo!..Thanks for posting this Ian and Doc..eomzeta1961-10/2/2006
4872 U.S. Researchers Win Nobel for Work on Genes [NYT] By NICHOLAS WADE PublisheDoc Bones-10/2/2006
486RNAi guys take this year's Medicine Nobel prize. Americans Win Medicine NobIan@SI-10/2/2006
4859:01AM AVI BioPharma presents positive preclinical data evaluating Neugene antisIan@SI-9/29/2006
484(SP Pharma) Market cap. is less then $30m, so some leverage. <g>nigel bates-9/27/2006
483SR Pharma plc to Receive Milestone Payments of up to US$95 Million (~£50 nigel bates-9/27/2006
482PFE Licenses RNAi Approach to Treating AMD from Quark Biotech: investorshub.comDewDiligence_on_SI-9/26/2006
481Acuity Pharmaceuticals Spins Weak AMD Results as ‘Positive’: investorshub.comDewDiligence_on_SI-9/11/2006
480Rosetta Genomics Files for IPO: urlcut.comDewDiligence_on_SI-9/7/2006
479Chuckle..and I drink decaf and ran out of provigil<geez>..eomzeta1961-8/31/2006
478Thanks for the post. I don't understand it either but getting RNAi to work kenhott-8/31/2006
477NEJM has an editorial on RNA interference..I don't keep up with this enuff tzeta1961-8/31/2006
47611:20AM Nastech Pharm awarded development grant for RNAi Therapeutics to preventIan@SI-8/29/2006
4759:34AM Enzo Biochem reports long term retention of antisense RNA in Phase I studIan@SI-8/15/2006
474These guys are doing some very nice stuff. What they are trying to do in generakenhott-8/15/2006
473This sounds like a pretty promising development, though the concept of attackingThomas-8/15/2006
472Thanks, Tuck. I wonder about Alnylam's decision to cut bait on their AMD caThomas-8/14/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News